CMR FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Peleg, A. Y.
Right arrow Articles by Paterson, D. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peleg, A. Y.
Right arrow Articles by Paterson, D. L.

 Previous Article

Clinical Microbiology Reviews, July 2008, p. 538-582, Vol. 21, No. 3
0893-8512/08/$08.00+0     doi:10.1128/CMR.00058-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Acinetobacter baumannii: Emergence of a Successful Pathogen

Anton Y. Peleg,1* Harald Seifert,2 and David L. Paterson3,4,5

Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts,1 Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Goldenfelsstrasse 19-21, 50935 Cologne, Germany,2 University of Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia,3 Pathology Queensland, Brisbane, Queensland, Australia,4 Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania5

Acinetobacter baumannii has emerged as a highly troublesome pathogen for many institutions globally. As a consequence of its immense ability to acquire or upregulate antibiotic drug resistance determinants, it has justifiably been propelled to the forefront of scientific attention. Apart from its predilection for the seriously ill within intensive care units, A. baumannii has more recently caused a range of infectious syndromes in military personnel injured in the Iraq and Afghanistan conflicts. This review details the significant advances that have been made in our understanding of this remarkable organism over the last 10 years, including current taxonomy and species identification, issues with susceptibility testing, mechanisms of antibiotic resistance, global epidemiology, clinical impact of infection, host-pathogen interactions, and infection control and therapeutic considerations.


* Corresponding author. Mailing address: Division of Infectious Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, 110 Francis Street, LMOB Suite GB, Boston, MA 02215. Phone: (617) 667-7000. Fax: (617) 632-7626. E-mail: apeleg{at}bidmc.harvard.edu


Clinical Microbiology Reviews, July 2008, p. 538-582, Vol. 21, No. 3
0893-8512/08/$08.00+0     doi:10.1128/CMR.00058-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Vaccine Immunol.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.